Guest Column: The Eight Billion Opportunity!  |  Finance: Covidonomics   |  Parent Interventions: Enrichment programmes help children build knowledge  |  Parent Interventions: Half of moms-to-be at risk of preeclampsia are missing out on preventive aspirin  |  Parent Interventions: First month of data shows children at low risk of COVID-19 infection  |  Teacher Insights: First-generation learners being left behind in global education  |  Teacher Insights: Deep learning: A new engine for ecological resource research  |  Parent Interventions: Study compares the health of Irish children to those across Europe and Canada  |  Policy Indications: MHRD ensures safe shifting of stranded students of Jawahar Navodaya Vidyalayas  |  National Edu News: RNA extraction kit Agappe Chitra Magna launched commercially  |  National Edu News: Certifying Quantum Entanglement: A step towards Quantum Security  |  Leadership Instincts: IIT Guwahati discovers new ways to prevent memory loss due to Alzheimer  |  Teacher Insights: 82 UG and 42 PG Non-Engineering MOOCs to be offered on SWAYAM  |  International Edu News: Handwashing 6-10 times a day linked to lower infection risk  |  Leadership Instincts: Bristol’s photon discovery, a major step toward large-scale quantum technologies  |  
March 24, 2020 Tuesday 01:39:15 PM IST

Anti-Malarial Drug for Treatment of Covid-19 approved by ICMR

Health Monitor

National Task Force for Covid-19 constituted by Indian Council of Medical Research (ICMR) has recommended the use of hydroxy-chloroquine for prophylaxis of SARS-Cov-2 as a preventive for high risk population that includes asymptomatic health care workers involved in the care of suspected or confirmed cases of Covid-19, asymptomatic household contacts of laboratory confirmed cases. However, Drugs Controller General of India has said that intake of such medicine should neot give a false sense of security.  Those taking such medicine should continue to take presribed public health measures such as frequent hand washing, respiratory etiquettes, social distancing of one metre and use of protective equipment where required. 
The high risk contacts of a positive case placed under chemo prophylaxis should remain in home quarantine while on prophylacti therapy. 
The dosage for Covid treatment is 400 mg twice a day on Day 1 followed by 400 mg once weekly for next next 7 weeks to be taken with meals. (asymptomatic healthcare workers), and 400 mg twice a day on Day 1, followed by 400 mg once weekly for next 3 weeks to be taken with meals for asymptomatic household contacts of laboratory confirmed cases.
It is not to be used in children below 15 years of age and contraindicated in persons with known case of retinopathy, known hypersensitivity to hydroxychioroquine, 4-aminoquinoline compounds.

More details in: